Memorin (ginkgo biloba) oral drops 40 mg/ml. 40 ml.

Description

Memorin composition
active substance: dry extract of ginkgo biloba leaves;
1 ml of oral drops contains a dry extract of Ginkgo biloba leaves (Ginkgonis folia) (1:50) (extractant – ethanol 80%), standardized to 24% ginkgoflavonoids and 6% terpenolactones, 40 mg;
excipient: ethanol 70%.

Dosage form
Oral drops.

Pharmacological properties
Memorin is a herbal remedy that normalizes cell metabolism. It also improves the rheological properties of blood, microcirculation, cerebral circulation, delivery of glucose and oxygen to the brain. Prevents aggregation of erythrocytes, inhibits platelet activating factor. In addition, it reveals a regulatory effect on the vascular system (dose-dependent), stimulates the production of an endothelium-dependent dilating factor, increases venous tone, dilates small arteries, regulating blood circulation in the vessels. Reduces the permeability of the vascular wall, has an antithrombotic effect, prevents the formation of free radicals, lipid peroxidation of cell membranes. Normalizes re-absorption, catabolism, release of neurotransmitters (dopamine, norepinephrine, acetylcholine), their ability to bind to receptors. Improves metabolism in tissues, has an antihypoxic effect, promotes increased utilization of oxygen, glucose, accumulation of macroergs in cells, normalization of mediator processes in the brain.

Indications
Memorin is used:

• with neurosensory deficiency of various origins (diabetic retinopathy, senile macular degeneration);
• with cognitive deficits of various origins (traumatic brain injury, discirculatory encephalopathy after a stroke, old age), which is manifested by a decrease in intellectual abilities, impaired attention, memory, fear, sleep disturbance);
• with intermittent claudication as a result of chronic obliterating arteriopathies of the lower extremities (grade II according to Fontaine);
• with visual impairment of vascular origin, a decrease in its acuity;
• with hearing impairment, vertigo, tinnitus, impaired coordination of vascular genesis;
• with Raynaud’s syndrome.

Contraindications
Do not use Memorin in case of hypersensitivity to ginkgo biloba extract, any component of the drug.

Application during pregnancy and lactation
Not recommended.

Method of administration and dosage
Memorin is used orally.
The standard dose is 40 mg (20 drops) 3 times / day. The average duration of treatment is 3 months.

• For cognitive disorders – 40 mg 3 times / day. The duration of treatment is at least eight weeks.
• With peripheral occlusive arterial disease, dizziness of vascular / involutional origin – 40 mg 2-3 times / day. The duration of treatment is at least eight weeks.
• With dizziness, the duration of treatment is no more than 6-8 weeks, with tinnitus – at least 12 weeks.

Overdose
No data available. There may be an increase in the manifestations of side effects. In case of an overdose, symptomatic treatment is prescribed.

Side effects:

• Neurological disorders: headache, fainting (including vasovagal), dizziness.
• Digestive disorders: dyspeptic symptoms, abdominal pain, nausea, diarrhea.
• Immune disorders: angioedema, shortness of breath, urticaria, rashes.
• Dermatological disorders: itching, skin inflammation, edema, redness, rash, eczema.
• Others: hemorrhages (in the eye, gastrointestinal, in the brain).

Storage conditions and periods
Store Memorin in undamaged packaging under such temperature conditions: up to +25 degrees Celsius. Store no more than three years from the date of manufacture.